The Zhitong Finance App learned that on August 18, iFLYTEK (02506.HK) announced the 2026 interim results. In the first half of the year, the company achieved revenue of 446 million yuan, an increase of 49.4% over the previous year, which significantly exceeded market expectations, and the growth trend was encouraging. Behind the high increase in performance is the dual resonance of the commercialization of the medical model and the dividends of the national health care reform policy — AI diagnosis and treatment assistants have ushered in a grassroots construction window. AI health assistants are in line with the direction of medical digitalization and health insurance fee control policies, the business accurately anchors policy orientation, and the ability of the big model continues to be transformed into revenue growth.

The Zhitong Finance App learned that on August 18, iFLYTEK (02506.HK) announced the 2026 interim results. In the first half of the year, the company achieved revenue of 446 million yuan, an increase of 49.4% over the previous year, which significantly exceeded market expectations, and the growth trend was encouraging. Behind the high increase in performance is the dual resonance of the commercialization of the medical model and the dividends of the national health care reform policy — AI diagnosis and treatment assistants have ushered in a grassroots construction window. AI health assistants are in line with the direction of medical digitalization and health insurance fee control policies, the business accurately anchors policy orientation, and the ability of the big model continues to be transformed into revenue growth.